Hasti Rouhani
YOU?
Author Swipe
View article: Cost-utility analysis of Macitentan Vs. Bosentan in pulmonary atrial hypertension
Cost-utility analysis of Macitentan Vs. Bosentan in pulmonary atrial hypertension Open
Macitentan is preferable to and dominant over bosentan in both effectiveness and expenditure. Thus, the therapeutic regimen containing macitentan is introduced as a favorable treatment strategy.
View article: PRS13 COST-UTILITY ANALYSIS OF MACITENTAN IN COMPARISON WITH BOSENTAN IN PULMONARY ATRIAL HYPERTENSION (PAH)
PRS13 COST-UTILITY ANALYSIS OF MACITENTAN IN COMPARISON WITH BOSENTAN IN PULMONARY ATRIAL HYPERTENSION (PAH) Open
View article: Biotin decorated PLGA nanoparticles containing SN-38 designed for cancer therapy
Biotin decorated PLGA nanoparticles containing SN-38 designed for cancer therapy Open
Active targeted chemotherapy is expected to provide more specific delivery of cytotoxic drugs to the tumor cells and hence reducing the side effects on healthy tissues. Due to the over expression of biotin receptors on cancerous cells as a…